Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Hematology|July 29, 2023
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research CommitteeShin-Ichi Fuchida, Mizuki Ogura, Tadao Ishida, et al.
International Journal of Hematology|November 9, 2018
Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myelomaShin-Ichi Fuchida, Kazutaka Sunami, Morio Matsumoto, et al.
Journal of Clinical Apheresis|June 28, 2013
Hematopoietic progenitor cell mobilization using low-dose cyclophosphamide and granulocyte colony-stimulating factor for multiple myelomaYuji Shimura, Junya Kuroda, Hitoji Uchiyama, et al.
International Journal of Hematology|August 13, 2015
The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinibYuji Shimura, Shigeo Horiike, Yasuhiko Tsutsumi, et al.
International Journal of Hematology|January 11, 2019
Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patientsNana Sasaki, Kazuho Shimura, Mihoko Yoshida, et al.
Blood|November 8, 2003
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemiaKazutaka Ozeki, Hitoshi Kiyoi, Yuka Hirose, et al.
ESC Heart Failure|November 28, 2018
Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathyYasuhiro Shintani, Atsushi Okada, Yoshiaki Morita, et al.
International Journal of Hematology|March 20, 2012
Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myelomaMiki Kiyota, Tsutomu Kobayashi, Shinichi Fuchida, et al.
International Journal of Hematology|November 26, 2009
Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myelomaKazutaka Sunami, Katsuji Shinagawa, Morio Sawamura, et al.
International Journal of Hematology|March 4, 2014
Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agentsJunya Kuroda, Yuji Shimura, Kensuke Ohta, et al.
Pageof 13